IMvigor130: Efficacy and safety from a phase III study of atezolizumab (atezo) as monotherapy or combined with platinum-based chemotherapy (PBC) vs placebo plus PBC in previously untreated locally advanced or metastatic urothelial carcinoma (mUC)


Grande E., Galsky M., Arranz Arija J. A. , De Santis M., Davis I. D. , De Giorgi U. F. F. , ...More

44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 27 September - 01 October 2019, vol.30, pp.888-889 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 30
  • City: Barcelona
  • Country: Spain
  • Page Numbers: pp.888-889